EFEMP1 and breast cancer: Moreover, fibulin 3 controlled triple-negative BC metastasis in a rodent experimental model of metastasis, and signals downstream of kisspeptin 1 receptor favored triple-negative BC cell invasion by activating the MAPK pathway and MMP 9 [115].